Medtronic marked a 4.2% change today, compared to -0.0% for the S&P 500. Is it a good value at today's price of $85.06? Only an in-depth analysis can answer that question, but here are some facts that can give you an idea:
-
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
-
Medtronic belongs to the Health Care sector, which has an average price to earnings (P/E) ratio of 24.45 and an average price to book (P/B) of 4.16
-
The company's P/B ratio is 2.2
-
Medtronic has a trailing 12 month Price to Earnings (P/E) ratio of 28.2 based on its trailing 12 month price to earnings (EPS) of $3.02 per share
-
Its forward P/E ratio is 16.3, based on its forward earnings per share (EPS) of $5.23
-
MDT has a Price to Earnings Growth (PEG) ratio of 7.22, which shows the company is overvalued when we factor growth into the price to earnings calculus.
-
Over the last four years, Medtronic has averaged free cash flows of $5,689,250,000.00, which on average grew 0.4%
-
MDT's gross profit margins have averaged 67.7 % over the last four years and during this time they had a growth rate of -0.7 % and a coefficient of variability of 2.9 %.
-
Medtronic has moved -27.7% over the last year compared to -6.8% for the S&P 500 -- a difference of -21.0%
-
MDT has an average analyst rating of hold and is -4.03% away from its mean target price of $88.64 per share